Anterix (ATEX) EBT (2013 - 2026)

Anterix's EBT history runs 14 years deep, the most recent figure standing at $20.4 million for Q1 2026.

• Quarterly EBT rose 106.25% year-over-year to $20.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.7 million (up 1109.56% YoY) and the FY2026 annual result came in at $95.7 million, up 1109.56% from the prior year.
• EBT was $20.4 million for Q1 2026 at Anterix, up from -$8.7 million in the prior quarter.
• Across five years, EBT topped out at $61.1 million in Q3 2025 and bottomed at -$14.3 million in Q2 2024.
• A 5-year average of $3.1 million and a median of -$2.4 million in 2023 frame the typical range for EBT.
• Annual changes were most pronounced in 2024 — EBT plunged 561.22% — and 2025, when it soared 587.03%.
• Anterix's EBT stood at -$7.8 million in 2022, then soared by 121.33% to $1.7 million in 2023, then jumped by 348.74% to $7.5 million in 2024, then sank by 215.74% to -$8.7 million in 2025, then soared by 335.55% to $20.4 million in 2026.
• Business Quant data shows ATEX's EBT at $20.4 million in Q1 2026, -$8.7 million in Q4 2025, and $61.1 million in Q3 2025.